More Americans can now get insulin for $35
cnn.com
cnn.com
This was an agreement between manufacturers and the government to guarantee a $35 co-pay for insulin.
https://www.cms.gov/newsroom/press-releases/president-trump-...
https://apnews.com/article/fact-checking-845638742817 [ Separately, the Trump administration implemented a program in which some Medicare Part D and Medicare Advantage plans voluntarily set the maximum copay for insulin at $35 per month. However, not all insulin products are necessarily covered by the plans that participate. It also does not affect costs for people who are uninsured or have other coverage.
That program remains in place, and Cubanski pointed out that the Biden administration supported expanding that initiative. A provision under the idling Build Back Better Act would have applied it to private insurers, for example.
That legislation also proposed allowing Medicare to negotiate the prices of certain drugs, including insulin. ]
It seems like there's more to it but I'm not sure.
Essentially, businesses are charging people to stay alive.
https://medicine.yale.edu/news-article/the-price-of-insulin-...
This 100% happened because of the Biden Administration got the Inflation Reduction Act passed, which has resulted in a cap on the price of insulin for Medicare beneficiaries by allowing the government to negotiate the price of certain drugs.
The state created their monopoly.
Yeah no. There is no benign justification for the three main insulin manufacturers raising prices in lockstep like the cartel they are.
There are lots of people who would happily produce insulin and undercut the existing prices, but the pharmaceutical industry pays a lot of money to keep the barriers to entry in place.
Which maybe explains precisely why we don’t see it happen: race to the bottom on pricing means reduced profitability. Why would you sign up your company to make less money?
https://www.fiercepharma.com/pharma/top-10-generic-drugmaker...
Yes! Note though that I'm not claiming a company cannot make money from producing generics.
But the question remains: why isn't some generic drug company then producing and making a killing (because they could underprice) in the insulin market? I think my original argument is the most likely reason, but I'm open to a stronger argument.
https://www.goodrx.com/healthcare-access/research/how-much-d...
But due to the bizarre regulatory system around healthcare in the US, manufacturers were incentivized to increase the list price (public price) all the while dropping the net price (confidential negotiated price with insurers).
This graph halfway down this page sums it up nicely: https://www.drugchannels.net/2020/08/five-top-drugmakers-rev...
Good idea right?
Well it ended up raising prices. Because companies were happy to tell a small insurer with a good price "too bad" so they didn't have to take a massive hit on their government account.
https://news.ycombinator.com/item?id=37561696
https://www.ftc.gov/news-events/news/press-releases/2023/11/...
https://www.ftc.gov/legal-library/browse/warning-letters/819...
Rationality? No. Regulation.
https://www.whitehouse.gov/briefing-room/statements-releases...
These are newer, better versions of insulin.
Although it’s a shame for profit’s have taken over drug discovery this way
It seems to me the main problem in the US healthcare is not the question if it's public or not but its large insane costs. The fact that other countries produce the same drugs for a small fraction of the price, sometimes pennies, is very telling of how rotten and inefficient the whole system is.
Imagine the price of milk slowly increasing to $100 per gallon over decades, due to greed, regulations, price cartels and speculation, and nobody noticing to ask why. People would probably being to ration milk only for those who need it the most like mothers who can't breastfeed their babies and there would be political pressure to create public milk banks and milk insurance and other public mechanisms. But all of that political energy would not solve the root causes of the problem.
Those new milk substitutes are great but they're not cheap. We can certainly get the people making them to sell them cheaper. The only downside is that the disincentive to create still newer milk substitutes.
If you're really happy with the status quo - or even really happy with plain old milk - then this is a good situation. If you wonder about something better then this is good touched by a bit of worry.
It does. Except it happened because the Biden administration forced them with threats. This was not done out of any kind of kindness.
I am honest, I don't know what to believe, and I don't directly know anyone who uses insulin to even have any anecdota.
Tangent and I don't know how productive it is to discuss, does this have anything with the GLP-1s (Ozempic/Mounjaro et al.)?
The pressure is coming from legislation, and while there is no doubt lobbying going on, am I wrong that it doesn't feel like the same relentless pushback from the triumvirate? Is it just that there is critical mass to drive change, or is the bitter fight not worth it when they have potential weight management products applicable to a much wider audience?
part of it is because medicare has to cap it because of biden. the other part is that california said "screw it we'll manufacture it and sell it at that price" so they didn't want to lose all money from the 6th largest economy in the world with the highest population in the us states.
> Is it just that there is critical mass to drive change
kinda if you count california
This should have been the opening paragraph.
There are several classes of insulin products available today:
Rapid-acting insulin, short-acting ("normal insulin"), intermediate-acting, long-acting, ultra-long acting and pre-mixed (a combination of the above).
Lantus, the first one mentioned in the article, is a long-acting insulin. Novolog, novolin, and levemir are rapid, sort/intermediate, and long respectively.
So it's not just basic insulin that is seeing the price reduction.
If they invested the money they've earned by selling insulin at very high margins for many years into research (as drug companies usually claim), then they should be fine.
If their business model depended solely on selling a single product and enjoying the margins, then it's good for the society. Someone else can produce it.
Who would have thought that having a single entity(not focused on profit) negotiating prices for pharmaceutical products would benefit consumers. Well, except every single country with universal healthcare.
If I've correctly understood the messaging around "if they give it to you, they can take it away".
Amazing how they manage to not mention that was forced by the Biden administration.
- Diet and moderate exercise are associated with a reduction in all cause mortality across the board.
- 'Blue Zones' are people who live to be 100 years or older. There's a great Netflix show about it if you want to learn more.
So most of them can keep enjoying their addiction to ultra-processed food?